CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 109 enrolled
Drug / intervention
Deep learning based reconstruction of T2-TSE sequencedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05820113
NCT05820113N/ACompleted

Deep Learning Super Resolution Reconstruction for Fast and Motion Robust T2-weighted Prostate MRI

University Hospital, Bonn·interventional·Posted Apr 19, 2023·Updated Apr 19, 2023

In Brief

A clinical study evaluating Deep learning based reconstruction of T2-TSE sequence for Prostate Cancer and Multiparametric MRI. Completed, enrolled 109 participants across 1 site.

Detailed Summary

The aim of this study was therefore to investigate a new unrolled DL super resolution reconstruction of an initially low-resolution Cartesian T2 turbo spin echo sequence (T2 TSE) and compare it qualitatively and quantitatively to standard high-resolution Cartesian and non-Cartesian T2 TSE sequences in the setting of prostate mpMRI with particular interest in image sharpness, conspicuity of lesions and acquisition time. Furthermore, the investigators assessed the agreement of assigned PI-RADS scores between deep learning super resolution and standard sequences.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesGermany
CollaboratorsPhilips Healthcare

Timeline

N/ACompletedFinished
2023202420252026
First PostedApr 19, 2023
Enrollment StartAug 1, 2022
Primary CompletionNov 30, 2022
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 3.2 years ago

Interventions

Deep learning based reconstruction of T2-TSE sequencedevice

A newly developed deep-learning based reconstruction of a primarily low-resolved T2-TSE sequence is included in the imaging protocol for evaluation of prostate cancer.